Osaka, Japan

Syuhei Yoshida

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 1


Location History:

  • Toyonaka, JP (2014)
  • Osaka, JP (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Syuhei Yoshida: Innovator in BACE1 Inhibitory Compounds

Introduction

Syuhei Yoshida is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit amyloid β production. His work is crucial in the fight against diseases associated with amyloid β proteins.

Latest Patents

Yoshida holds three patents, with his latest inventions focusing on dihydrooxazine and oxazepine derivatives that exhibit BACE1 inhibitory activity. These compounds are designed to inhibit the production of amyloid β, making them valuable as therapeutic or prophylactic agents for diseases related to amyloid β protein deposition.

Career Highlights

Yoshida's career is marked by his dedication to research and innovation in the pharmaceutical industry. He is currently employed at Shionogi & Company Limited, where he continues to advance his research in medicinal chemistry.

Collaborations

Throughout his career, Yoshida has collaborated with notable colleagues, including Ken-ichi Kusakabe and Kenji Nakahara. These partnerships have contributed to the success of his research and the development of his patented compounds.

Conclusion

Syuhei Yoshida's work in developing BACE1 inhibitory compounds represents a significant advancement in the field of medicinal chemistry. His contributions are vital for the ongoing research into therapies for diseases associated with amyloid β proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…